• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症(MS)患者的神经泌尿学评估:一种新的评估算法

Neurourological assessment in people with multiple sclerosis (MS): a new evaluated algorithm.

作者信息

Domurath Burkhard, Kurze Ines, Kirschner-Hermanns Ruth, Kaufmann Albert, Feneberg Wolfgang, Schmidt Paul, Henze Thomas, Flachenecker Peter, Brandt Anna, Vance Will Nelson, Beck Janina, Vonthien Manuela, Ratering Kerstin

机构信息

Neuro-Urological Center, Clinic Beelitz GmbH, Neurological Rehabilitation Clinic, Paracelsusring 6 a, 14547 Beelitz Heilstätten, Germany.

Spinal Cord Injury Center, Clinic for Paraplegiologia and Neuro-Urology Robert-Koch-Allee 9, 99438 Bad Berka, Germany.

出版信息

Mult Scler Relat Disord. 2020 Sep;44:102248. doi: 10.1016/j.msard.2020.102248. Epub 2020 May 30.

DOI:10.1016/j.msard.2020.102248
PMID:32562907
Abstract

BACKGROUND

Neurogenic lower urinary tract dysfunction (NULTD) is common in patients with multiple sclerosis (MS); nevertheless, it is often underestimated, underdiagnosed, and undertreated due to patients' sense of shame, variability of symptoms, as well as lack of communication between neurologists and urologists, despite the availability of several guidelines based on scientific evidence and expert opinion.

OBJECTIVE

This study was conducted to develop an easy-to-perform algorithm for diagnosing neurogenic lower urinary tract disease in patients with MS for daily neurological and urological routine, including the identification of red flags.

METHODS

In consensus group meetings, interprofessional experts (neurologists, urologists, neurourologists, nurses, nurse practitioners, occupational therapists, physical therapists as well as representatives of national MS centers, self-care groups, social care, residential care, and health-aid-providers) developed a diagnostic algorithm to detect NULTD in patients with MS. Subsequently, the group evaluated the algorithm in 121 patients with MS using micturition diary, post-void residual volume, uroflowmetry, and urodynamic studies. Statistical analysis was conducted on the basis of logistic regression models to compare patients with normal and abnormal urodynamic examinations. Differentiation was performed using selected diagnostic parameters as well as standard performance measures for binary classifiers to assess prognostic quality.

RESULTS

The following four parameters allowed to diagnose NLUTD in patients with MS: post-void residual urine volume, rate of urinary tract infections during the past 6 months, micturition frequency, and incontinence. According to statistical analysis, the following thresholds could be defined: post-void residual volume (PVR) ≥70 mL (Odds Ratio (OR) = 1.24; 95% CI:[1.07,1.62]), urinary tract infection (UTI) rate - none in 6 months (OR = 2.03; 95% CI:[1.04,6.68]), and micturition frequency >13/day, standardized on 2000 mL urine excretion (OR = 1.24; 95% CI:[1.07,1.49]). Uroflowmetry served as a further predictor of urodynamically measurable urinary bladder dysfunction (OR = 4.80; 95% CI: [1.41, 19.21]). Interestingly, patients without any complaints of NLUTD had an abnormal urodynamic examination in >50% of the cases. The entire algorithm has a sensitivity of 95%.

CONCLUSIONS

All patients with MS should undergo a basic examination to detect NLUTDs. Within the algorithm developed in this study, four easy-to-collect parameters may reveal NLUTD in patients with MS.

摘要

背景

神经源性下尿路功能障碍(NULTD)在多发性硬化症(MS)患者中很常见;然而,由于患者的羞耻感、症状的变异性,以及神经科医生和泌尿科医生之间缺乏沟通,尽管有基于科学证据和专家意见的多项指南,但该病常常被低估、漏诊和治疗不足。

目的

本研究旨在开发一种易于执行的算法,用于在日常神经科和泌尿科诊疗中诊断MS患者的神经源性下尿路疾病,包括识别警示信号。

方法

在多专业专家共识会议上(神经科医生、泌尿科医生、神经泌尿科医生、护士、执业护士、职业治疗师、物理治疗师以及国家MS中心、自我护理团体、社会护理、住宿护理和健康援助提供者的代表),制定了一种诊断算法,以检测MS患者的NULTD。随后,该小组使用排尿日记、排尿后残余尿量、尿流率和尿动力学研究对121例MS患者的算法进行了评估。基于逻辑回归模型进行统计分析,以比较尿动力学检查正常和异常的患者。使用选定的诊断参数以及二元分类器的标准性能指标进行区分,以评估预后质量。

结果

以下四个参数可用于诊断MS患者的NLUTD:排尿后残余尿量、过去6个月内的尿路感染率、排尿频率和尿失禁。根据统计分析,可定义以下阈值:排尿后残余尿量(PVR)≥70 mL(优势比(OR)=1.24;95%置信区间:[1.07,1.62]),尿路感染(UTI)率——6个月内无感染(OR = 2.03;95%置信区间:[1.04,6.68]),以及排尿频率>13次/天(以2000 mL尿量排泄为标准)(OR = 1.24;95%置信区间:[1.07,1.49])。尿流率可作为尿动力学可测量的膀胱功能障碍的进一步预测指标(OR = 4.80;95%置信区间:[1.41,19.21])。有趣的是,没有任何NLUTD主诉的患者中,超过50%的病例尿动力学检查异常。整个算法的敏感性为95%。

结论

所有MS患者均应接受基本检查以检测NLUTD。在本研究开发的算法中,四个易于收集的参数可能揭示MS患者的NLUTD。

相似文献

1
Neurourological assessment in people with multiple sclerosis (MS): a new evaluated algorithm.多发性硬化症(MS)患者的神经泌尿学评估:一种新的评估算法
Mult Scler Relat Disord. 2020 Sep;44:102248. doi: 10.1016/j.msard.2020.102248. Epub 2020 May 30.
2
[Current aspects of neurogenic dysfunctions of the lower urinary tract in multiple sclerosis].[多发性硬化症下尿路神经源性功能障碍的当前研究进展]
Nervenarzt. 2021 Apr;92(4):349-358. doi: 10.1007/s00115-020-01046-0. Epub 2021 Jan 5.
3
Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis.《多发性硬化症患者神经源性下尿路功能障碍多学科管理共识文件》
Neurourol Urodyn. 2020 Feb;39(2):762-770. doi: 10.1002/nau.24276. Epub 2020 Jan 15.
4
Clinical Predictors of Neurogenic Lower Urinary Tract Dysfunction in Persons with Multiple Sclerosis.多发性硬化症患者神经源性下尿路功能障碍的临床预测因素
Diagnostics (Basel). 2022 Jan 13;12(1):191. doi: 10.3390/diagnostics12010191.
5
Neurogenic Lower Urinary Tract Dysfunction in Asymptomatic Patients with Multiple Sclerosis.无症状多发性硬化症患者的神经源性下尿路功能障碍
Biomedicines. 2022 Dec 15;10(12):3260. doi: 10.3390/biomedicines10123260.
6
Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis.关于神经科医生在多发性硬化症神经源性下尿路功能障碍管理中作用的共识指南。
Clin Neurol Neurosurg. 2013 Oct;115(10):2033-40. doi: 10.1016/j.clineuro.2013.06.018. Epub 2013 Jul 20.
7
[Clinical and urodynamic risk factors of recurrent urinary tract infections in patients with multiple sclerosis.].[多发性硬化症患者复发性尿路感染的临床和尿动力学危险因素。]
Arch Esp Urol. 2019 Dec;72(10):1010-1017.
8
[Neuro-urological diagnostics and treatment of non-traumatic/degenerative neurogenic lower urinary tract dysfunction exemplified by multiple sclerosis].[以多发性硬化症为例的非创伤性/退行性神经源性下尿路功能障碍的神经泌尿诊断与治疗]
Aktuelle Urol. 2024 Aug;55(4):315-325. doi: 10.1055/a-2281-7924. Epub 2024 Apr 23.
9
Does Post-Void Residual Volume Predict Worsening Urological Symptoms in Patients with Multiple Sclerosis?残余尿容积能否预测多发性硬化症患者下尿路症状的恶化?
J Urol. 2018 Oct;200(4):868-874. doi: 10.1016/j.juro.2018.04.068. Epub 2018 Apr 24.
10
Lower urinary tract dysfunction in patients with multiple sclerosis: A post-void residual analysis of 501 cases.多发性硬化症患者的下尿路功能障碍:501例病例的排尿后残余尿量分析
Mult Scler Relat Disord. 2020 Oct;45:102378. doi: 10.1016/j.msard.2020.102378. Epub 2020 Jul 5.

引用本文的文献

1
Analysis of the onset of lower urinary tract symptoms in multiple scleroris patients.多发性硬化症患者下尿路症状的发病情况分析。
World J Urol. 2025 May 31;43(1):342. doi: 10.1007/s00345-025-05709-y.
2
Impact of Siponimod on Clinical and Radiological Parameters of Secondary Progressive Multiple Sclerosis: A Real-World Prospective Study.西尼莫德对继发进展型多发性硬化症临床和影像学参数的影响:一项真实世界前瞻性研究。
J Clin Neurol. 2024 Nov;20(6):591-598. doi: 10.3988/jcn.2024.0149.
3
Neurogenic Lower Urinary Tract Symptoms, Fatigue, and Depression-Are There Correlations in Persons with Multiple Sclerosis?
神经源性下尿路症状、疲劳与抑郁——多发性硬化症患者中存在关联吗?
Biomedicines. 2023 Aug 4;11(8):2193. doi: 10.3390/biomedicines11082193.
4
[Neurology meets Urology : Overview of urologically relevant neurological diseases].[神经学与泌尿学的交汇:泌尿学相关神经疾病概述]
Urologie. 2023 Sep;62(9):965-975. doi: 10.1007/s00120-023-02168-4. Epub 2023 Aug 18.
5
Multiple sclerosis and lower urinary tract symptoms: A survey of prevalence, characteristic and urological evaluations.多发性硬化症与下尿路症状:患病率、特征及泌尿外科评估调查
SAGE Open Med. 2023 Jun 25;11:20503121231178047. doi: 10.1177/20503121231178047. eCollection 2023.
6
Neurogenic Lower Urinary Tract Dysfunction in Asymptomatic Patients with Multiple Sclerosis.无症状多发性硬化症患者的神经源性下尿路功能障碍
Biomedicines. 2022 Dec 15;10(12):3260. doi: 10.3390/biomedicines10123260.
7
Clinical Predictors of Neurogenic Lower Urinary Tract Dysfunction in Persons with Multiple Sclerosis.多发性硬化症患者神经源性下尿路功能障碍的临床预测因素
Diagnostics (Basel). 2022 Jan 13;12(1):191. doi: 10.3390/diagnostics12010191.